Literature DB >> 10548215

Cytokine-induced intestinal epithelial hyperpermeability: role of nitric oxide.

A M Chavez1, M J Menconi, R A Hodin, M P Fink.   

Abstract

OBJECTIVE: Incubation of enterocytic monolayers with interferon (IFN)-gamma increases nitric oxide (NO) production and permeability, but NO synthesis inhibitors ameliorate the development of IFN-gamma-induced hyperpermeability. Induction of inducible nitric oxide synthase (iNOS), an isoform of the enzyme responsible for NO biosynthesis, is often enhanced by the synergistic effects of multiple cytokines. Moreover, many of the cytopathic effects of NO are mediated by peroxynitrite, which is produced by the reaction of NO with superoxide radical anion. In the present study, we sought to determine whether combinations of several proinflammatory cytokines, including IFN-gamma, interleukin-1beta, and tumor necrosis factor-alpha, have synergistic effects on the induction of iNOS expression and/or hyperpermeability to hydrophilic solutes in cultured enterocytic monolayers. We also assessed the effects of aminoguanidine (a relatively selective iNOS inhibitor), L-N(G)-monomethyl arginine (an isoform-nonselective NO synthase inhibitor), and Tiron (a superoxide radical anion scavenger) on the development of cytokine-induced hyperpermeability.
DESIGN: Caco-2 monolayers were incubated under control conditions or with IFN-gamma, interleukin-1beta, or tumor necrosis factor-alpha alone, pairwise combinations of these cytokines, or all three cytokines together (cytomix; CM). iNOS messenger RNA (mRNA) expression was assessed using Northern blot analysis. The permeability of Caco-2 monolayers growing on permeable supports in bicameral chambers was assessed by measuring the apical-to-basolateral flux of fluorescein disulfonic acid. The concentration of nitrate plus nitrite in culture supernatants, an indirect measure of NO production, was determined using the Griess reaction.
RESULTS: After 24 hrs of incubation, up-regulation of iNOS mRNA expression was evident only in cells exposed to IFN-gamma-containing formulations. Expression of iNOS mRNA was far greater in cells incubated with CM than in cells treated with IFN-gamma alone or either of the two-component IFN-gamma-containing cytokine combinations. Compared with IFN-gamma, CM resulted in a higher rate of NO production over 48 hrs of incubation. The permeability of Caco-2 monolayers increased by approximately six-fold and approximately 20-fold after incubation for 48 hrs with IFN-gamma alone and CM, respectively. The increase in permeability induced by incubation with CM was significantly ameliorated by the addition of aminoguanidine, L-N(G)-monomethyl arginine, or Tiron.
CONCLUSIONS: IFN-gamma-containing combinations of cytokines are potent inducers of iNOS in cultured enterocytic monolayers. Peroxynitrite may be an important mediator of cytokine-induced gut epithelial hyperpermeability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10548215     DOI: 10.1097/00003246-199910000-00030

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  30 in total

1.  Enteral nutrition prevents remote organ injury and death after a gut ischemic insult.

Authors:  K Fukatsu; B L Zarzaur; C D Johnson; A H Lundberg; H G Wilcox; K A Kudsk
Journal:  Ann Surg       Date:  2001-05       Impact factor: 12.969

Review 2.  Intestinal crosstalk: a new paradigm for understanding the gut as the "motor" of critical illness.

Authors:  Jessica A Clark; Craig M Coopersmith
Journal:  Shock       Date:  2007-10       Impact factor: 3.454

3.  Burn-induced gut barrier injury is attenuated by phosphodiesterase inhibition: effects on tight junction structural proteins.

Authors:  Todd W Costantini; William H Loomis; James G Putnam; Dana Drusinsky; Jessica Deree; Sunghyuk Choi; Paul Wolf; Andrew Baird; Brian Eliceiri; Vishal Bansal; Raul Coimbra
Journal:  Shock       Date:  2009-04       Impact factor: 3.454

4.  Interaction between enteric epithelial cells and Peyer's patch lymphocytes in response to Shigella lipopolysaccharide: effect on nitric oxide and IL-6 release.

Authors:  Jie Chen; Chuen-Pei Ng; Dewi K Rowlands; Peng-Hui Xu; Jie-Ying Gao; Yiu-Wa Chung; Hsiao-Chang Chan
Journal:  World J Gastroenterol       Date:  2006-06-28       Impact factor: 5.742

5.  NF-κΒ inhibition is ineffective in blocking cytokine-induced IL-8 production but P38 and STAT1 inhibitors are effective.

Authors:  Quan Wang; Nathan Huber; Greg Noel; Lauren Haar; Yizhi Shan; Timothy A Pritts; Cora K Ogle
Journal:  Inflamm Res       Date:  2012-05-23       Impact factor: 4.575

6.  Gut hyperpermiability after ischemia and reperfusion: attenuation with adrenomedullin and its binding protein treatment.

Authors:  Shinya Higuchi; Rongqian Wu; Mian Zhou; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

7.  Extracellular activation of arginase-1 decreases enterocyte inducible nitric oxide synthase activity during systemic inflammation.

Authors:  Keita Miki; Abhai Kumar; Runkuan Yang; Meaghan E Killeen; Russell L Delude
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-08-27       Impact factor: 4.052

8.  Non-equilibrium and differential function between intraepithelial and lamina propria virus-specific TCRalphabeta(+) CD8alphabeta(+) T cells in the small intestinal mucosa.

Authors:  D Isakov; A Dzutsev; I M Belyakov; J A Berzofsky
Journal:  Mucosal Immunol       Date:  2009-07-01       Impact factor: 7.313

Review 9.  The inflammatory & neurodegenerative (I&ND) hypothesis of depression: leads for future research and new drug developments in depression.

Authors:  Michael Maes; Raz Yirmyia; Jens Noraberg; Stefan Brene; Joe Hibbeln; Giulia Perini; Marta Kubera; Petr Bob; Bernard Lerer; Mario Maj
Journal:  Metab Brain Dis       Date:  2008-12-16       Impact factor: 3.584

10.  Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Haichao Wang; Steven A Blau; Thanjavur S Ravikumar; Ping Wang
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.